Dynamics of the cytokine profile in achieving the therapeutic effect of allergen-specific immunotherapy in children with allergic rhinitis and bronchial asthma

Allergen-specific immunotherapy is a pathogenetic method for the treatment of IgE-mediated allergic diseases.

Objective. To evaluate effectiveness of allergen-specific immunotherapy in 471 children with allergic rhinitis and bronchial asthma, as well to analyze the dynamics of the cytokine profile at baseline and 1 year after the start of treatment in 86 children. The research was supported by a grant from the International Scientific Council for Young Scientists of Kazan State Medical University.

Results. Analysis of the data obtained demonstrated that allergen-specific immunotherapy is a highly effective method of treating children with allergic rhinitis and atopic bronchial asthma. The dynamics of the level of the studied cytokines during treatment indirectly indicates an increase in the functional activity of adaptive subpopulations of regulatory T-lymphocytes (T-reg) and B-lymphocytes (B-reg) with a decrease in the activity of Th2 lymphocytes, which may indicate the reconstruction of the immune response and possible disease-modifying effect.

1. Akdis C.A., Agache I. Global atlas of allergy. Published by EAACI, 2014; 388

2. Pawankar R., Canonica G.W., Holgate S.T., Lockey R.F., Blaiss M. The WAO White book on allergy. 2013; 20

3. Haitov R.M., Il’ina N.I. Clinical guidelines. Allergology and Clinical Immunology. Moscow: GEOTAR-Media, 2019; 302–316. (in Russ.)

4. BroĪek J.L., Bousquet J., Agache I., Agarwal A., Bachert C., Bosnic-Anticevich S. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines – 2016 Revision. J Allergy Clin Immunol 2017; 140(4): 950–958. DOI: 10.1016/j.jaci.2017.03.050

5. Agache I., Akdis C.A., Chivato T., Hellings P., Hoffman-Sommergruber K., Jutel M. EAACI White paper on Research, Innovation and Quality Care. Published by EAACI, 2018; 166

6. GINA. Global Initiative for Asthma/Global Strategy for Asthma Management and Prevention, 2021. [Электронный ресурс]. Ссылка активна на 20.06.2021.URL: https://ginasthma.org

7. Bousquet J., Schunemann H.J., Akdis T., Bachert C., Erhola M., Hellings P.W. et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol 2020; 145(1): 70–80. DOI: 10.1016/j.jaci.2019.06.049

8. Ссылка активна на 20.06.2021. URL: https://raaci.ru/dat/pdf/allergic_rhinitis Allergic rhinitis. Clinical guidelines. 2020. (in Russ.)

9. Bronchial astma. Clinical guidelines. Russian Respiratory Society Ministry of Health of the Russian Federation, 2019. (in Russ.)

10. Arasi S., Corsello G., Villani A., Pajno G.B. The future outlook on allergen immunotherapy in children: 2018 and beyond. Ital J Pediatr 2018; 44(1): 80. DOI: 10.1186/s13052-018-0519-4

11. Roberts G., Pfaar O., Akdis C.A., Ansotegui I.J., Durham S.R., Gerth van Wijk R. et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy 2018; 73(4):765–798. DOI: 10.1111/all.13317

12. Halken S., Larenas-Linnemann D., Roberts G., Calderón M.A., Angier E., Pfaar O. et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol 2017; 28(8): 728–745. DOI: 10.1111/pai.12807

13. Rudman Spergel A.K., Minnicozzi М., Wheatley L.M., Togias A. Is Allergen Immunotherapy in Children Disease Modifying? A Review of the Evidence. Curr Allergy Asthma Rep 2018; 18(9): 47. DOI: 10.1007/s11882-018-0801-y

14. Shamji M.H., Layhadi J.A., Sharif H., Penagos M., Durham S.R. Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens. J Allergy Clin Immunol 2021; 9(5): 2213–2198. DOI: 10.1016/J.JAIP.2021.03.029

15. Shamji M.H., Kappen M., Akdis E., Jensen-Jarolim E.K., Knol E.F., Kleine-Tebbeet J. et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy 2017; 72(8): 1156–1173. DOI: 10.1111/all.13138

16. Akdis C.A., Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J 2015; 8: 1–12. DOI: 10.1186/s40413-015-0063-2

17. Pfaar O., Demoly P., Gerth van Wijk R., Bonini S., Bousquet J., Canonica G.W. et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014; 69: 854–867. DOI: 10.1111/all.12383

18. Glanc S. Biomedical statistics. Moscow: Praktika, 1998; 459. (in Russ.)

19. Rebrova O.Yu. Statistical analysis of medical data. Application Package Application Statistics. Meditsina: MediaSfera, 2002; 312. (in Russ.)

20. Hafiz’yanova R.H., Burykin I.M., Aleeva G.N. Mathematical statistics in experimental and clinical pharmacology. Kazan’: Meditsina, 2006; 373. (in Russ.)